دورية أكاديمية
أعرض في EDS

Naringin and Naringenin Polyphenols in Neurological Diseases: Understandings from a Therapeutic Viewpoint.

التفاصيل البيبلوغرافية
العنوان: Naringin and Naringenin Polyphenols in Neurological Diseases: Understandings from a Therapeutic Viewpoint.
المؤلفون: Emran TB; Department of Pharmacy, BGC Trust University Bangladesh, Chittagong 4381, Bangladesh.; Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, Bangladesh., Islam F; Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, Bangladesh., Nath N; Department of Pharmacy, International Islamic University Chittagong, Chittagong 4318, Bangladesh., Sutradhar H; Department of Pharmacy, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh., Das R; Department of Pharmacy, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh., Mitra S; Department of Pharmacy, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh., Alshahrani MM; Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Najran University, P.O. Box 1988, Najran 61441, Saudi Arabia., Alhasaniah AH; Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Najran University, P.O. Box 1988, Najran 61441, Saudi Arabia., Sharma R; Department of Rasa Shastra and Bhaishajya Kalpana, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, Uttar Pradesh, India.
المصدر: Life (Basel, Switzerland) [Life (Basel)] 2022 Dec 29; Vol. 13 (1). Date of Electronic Publication: 2022 Dec 29.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101580444 Publication Model: Electronic Cited Medium: Print ISSN: 2075-1729 (Print) Linking ISSN: 20751729 NLM ISO Abbreviation: Life (Basel) Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI AG, 2011-
مستخلص: The glycosides of two flavonoids, naringin and naringenin, are found in various citrus fruits, bergamots, tomatoes, and other fruits. These phytochemicals are associated with multiple biological functions, including neuroprotective, antioxidant, anticancer, antiviral, antibacterial, anti-inflammatory, antiadipogenic, and cardioprotective effects. The higher glutathione/oxidized glutathione ratio in 3-NP-induced rats is attributed to the ability of naringin to reduce hydroxyl radical, hydroperoxide, and nitrite. However, although progress has been made in treating these diseases, there are still global concerns about how to obtain a solution. Thus, natural compounds can provide a promising strategy for treating many neurological conditions. Possible therapeutics for neurodegenerative disorders include naringin and naringenin polyphenols. New experimental evidence shows that these polyphenols exert a wide range of pharmacological activity; particular attention was paid to neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, as well as other neurological conditions such as anxiety, depression, schizophrenia, and chronic hyperglycemic peripheral neuropathy. Several preliminary investigations have shown promising evidence of neuroprotection. The main objective of this review was to reflect on developments in understanding the molecular mechanisms underlying the development of naringin and naringenin as potential neuroprotective medications. Furthermore, the configuration relationships between naringin and naringenin are discussed, as well as their plant sources and extraction methods.
References: J Clin Neurol. 2013 Apr;9(2):91-6. (PMID: 23626646)
EMBO J. 1999 Nov 1;18(21):6027-36. (PMID: 10545114)
Biosci Biotechnol Biochem. 2018 Jul;82(7):1216-1224. (PMID: 29618282)
Neurochem Int. 2012 Jan;60(2):208-12. (PMID: 22122807)
Environ Toxicol. 2019 Jul;34(7):788-795. (PMID: 30843661)
Annu Rev Pharmacol Toxicol. 2007;47:89-116. (PMID: 16968214)
Med Sci Monit. 2020 Jan 04;26:e918772. (PMID: 31901198)
PLoS One. 2013 Nov 04;8(11):e78033. (PMID: 24223757)
Neurochem Res. 2014 Aug;39(8):1405-15. (PMID: 24842554)
J Nutr Biochem. 2016 Feb;28:140-6. (PMID: 26878791)
Biomed Pharmacother. 2022 Jun;150:112932. (PMID: 35413599)
Zhong Xi Yi Jie He Xue Bao. 2012 Dec;10(12):1482-9. (PMID: 23257145)
J Med Food. 2010 Aug;13(4):976-84. (PMID: 20673063)
Biochem Biophys Res Commun. 2015 May 29;461(2):287-92. (PMID: 25881506)
J Basic Clin Physiol Pharmacol. 2015 Sep;26(5):471-7. (PMID: 26030791)
Neurochem Res. 2016 Sep;41(9):2352-66. (PMID: 27209303)
Neurology. 1981 Apr;31(4):371-6. (PMID: 7194429)
Exp Neurol. 2006 Jun;199(2):265-73. (PMID: 16515786)
Curr Treat Options Neurol. 2019 Feb 26;21(3):10. (PMID: 30806821)
Neurochem Int. 2012 Dec;61(7):1081-93. (PMID: 22898296)
Scand J Urol Nephrol. 2004;38(5):405-16. (PMID: 15764253)
Rev Neurosci. 2006;17(1-2):253-66. (PMID: 16703956)
Biol Pharm Bull. 2021 Jan 1;44(1):51-56. (PMID: 33162492)
Biol Pharm Bull. 2012;35(10):1836-40. (PMID: 23037174)
J Nutr Biochem. 2014 Jul;25(7):801-6. (PMID: 24797334)
Methods Mol Biol. 2019;2034:57-67. (PMID: 31392677)
Neuroscience. 2012 Dec 27;227:134-43. (PMID: 22871521)
Pharmacol Res. 2018 Oct;136:1-20. (PMID: 30121358)
Trends Neurosci. 2008 May;31(5):234-42. (PMID: 18395805)
Neurotox Res. 2021 Aug;39(4):1023-1043. (PMID: 33534126)
Int Immunopharmacol. 2010 Aug;10(8):943-50. (PMID: 20546946)
Biochem Biophys Res Commun. 2001 Jun 15;284(3):681-8. (PMID: 11396955)
Int J Neurosci. 2014 Apr;124(4):227-35. (PMID: 23919560)
Int J Environ Res Public Health. 2021 Jan 30;18(3):. (PMID: 33573212)
Biol Pharm Bull. 2011;34(3):360-5. (PMID: 21372385)
Annu Rev Pathol. 2011;6:193-222. (PMID: 21034221)
Planta Med. 2014 Apr;80(6):437-51. (PMID: 24710903)
Neuroscience. 2013 Jan 29;230:157-71. (PMID: 23103795)
J Agric Food Chem. 2004 Mar 24;52(6):1520-5. (PMID: 15030205)
J Biochem Mol Toxicol. 2022 Sep;36(9):e23121. (PMID: 35670529)
Eur J Pharmacol. 2009 Aug 15;616(1-3):147-54. (PMID: 19577560)
Neurochem Res. 2014 Jul;39(7):1254-62. (PMID: 24728904)
Tohoku J Exp Med. 2008 Jun;215(2):133-40. (PMID: 18577842)
Pharmacol Res. 2019 Jan;139:452-459. (PMID: 30527894)
Dement Geriatr Cogn Disord. 2004;17(3):151-7. (PMID: 14739537)
Adv Nutr. 2014 Jul 14;5(4):404-17. (PMID: 25022990)
Biosci Biotechnol Biochem. 1994 Aug;58(8):1479-85. (PMID: 7765281)
Behav Brain Res. 2010 Jan 5;206(1):38-46. (PMID: 19716383)
Neurotox Res. 2018 Apr;33(3):656-670. (PMID: 29427283)
J Alzheimers Dis. 2017;57(4):975-999. (PMID: 27567878)
Biol Psychiatry. 2016 Feb 1;79(3):222-33. (PMID: 26410353)
Neural Regen Res. 2014 Aug 15;9(16):1514-7. (PMID: 25317167)
Am J Physiol Gastrointest Liver Physiol. 2000 Dec;279(6):G1148-54. (PMID: 11093936)
Syst Rev. 2021 Mar 29;10(1):89. (PMID: 33781348)
Pharmacol Biochem Behav. 2012 Jul;102(1):13-20. (PMID: 22741174)
J Mol Neurosci. 2015 Jun;56(2):349-62. (PMID: 25896911)
Food Chem Toxicol. 2019 Oct;132:110646. (PMID: 31252025)
Clin Pharmacol Ther. 1995 Oct;58(4):365-73. (PMID: 7586927)
CNS Drugs. 2001;15(10):797-817. (PMID: 11602005)
Kidney Int. 2005 Apr;67(4):1216-33. (PMID: 15780075)
Brain Res Bull. 2017 Jul;133:42-50. (PMID: 28011192)
Food Chem Toxicol. 2018 Nov;121:95-108. (PMID: 30130594)
J Clin Invest. 2006 Jul;116(7):1744-54. (PMID: 16823471)
Free Radic Biol Med. 2013 Sep;62:132-144. (PMID: 23380027)
J Pharm Pharmacol. 2020 Sep;72(9):1176-1185. (PMID: 32436614)
Iran J Pharm Res. 2014 Spring;13(2):493-503. (PMID: 25237344)
Neuropharmacology. 2014 Apr;79:380-8. (PMID: 24333330)
Molecules. 2020 Nov 23;25(22):. (PMID: 33238435)
Neurotherapeutics. 2014 Jan;11(1):6-23. (PMID: 24085420)
Front Pharmacol. 2021 Jul 02;12:651156. (PMID: 34276359)
Food Funct. 2021 Mar 21;12(6):2715-2725. (PMID: 33667286)
J Med Food. 2006 Spring;9(1):49-54. (PMID: 16579728)
Free Radic Res. 2005 Oct;39(10):1119-25. (PMID: 16298737)
Cancer Cell Int. 2015 Apr 24;15:46. (PMID: 26074733)
Neurosci Biobehav Rev. 2011 Jan;35(3):878-93. (PMID: 20974172)
Laeknabladid. 2014 Jul;100(7-8):393-401. (PMID: 25125437)
Prog Neuropsychopharmacol Biol Psychiatry. 2012 Oct 1;39(1):175-81. (PMID: 22709719)
Comp Biochem Physiol C Toxicol Pharmacol. 2021 Jan;239:108893. (PMID: 32949818)
Acta Crystallogr C. 2005 Dec;61(Pt 12):o728-30. (PMID: 16330860)
Eur J Pharmacol. 2007 Feb 5;556(1-3):200-6. (PMID: 17141756)
BMC Complement Altern Med. 2016 Nov 25;16(1):483. (PMID: 27887650)
Cell Stress Chaperones. 2019 Nov;24(6):1091-1099. (PMID: 31446555)
Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:135-41. (PMID: 24121063)
Eur J Pharmacol. 2015 Oct 5;764:195-201. (PMID: 26148826)
Neural Regen Res. 2017 Mar;12(3):470-477. (PMID: 28469664)
Biomed Pharmacother. 2022 May;149:112877. (PMID: 35367766)
Neuromolecular Med. 2019 Sep;21(3):250-261. (PMID: 31037465)
Korean J Pain. 2022 Jul 1;35(3):291-302. (PMID: 35768984)
Ann N Y Acad Sci. 1998 Nov 20;854:435-42. (PMID: 9928450)
Clin Pharmacol Ther. 1993 Dec;54(6):589-94. (PMID: 8275614)
Mol Med Rep. 2021 May;23(5):. (PMID: 33760152)
Neuromolecular Med. 2020 Jun;22(2):314-330. (PMID: 31916219)
Br J Clin Pharmacol. 1999 Oct;48(4):543-52. (PMID: 10583025)
Neurol Sci. 2014 May;35(5):741-51. (PMID: 24337945)
Biochim Biophys Acta. 2009 Oct;1792(10):931-40. (PMID: 19061951)
Int J Neurosci. 2019 Jun;129(6):534-539. (PMID: 30433834)
J Mol Neurosci. 2021 Mar;71(3):431-445. (PMID: 32767187)
Gene. 2016 Oct 30;592(1):128-133. (PMID: 27432064)
J Biochem Mol Biol. 2004 Mar 31;37(2):139-43. (PMID: 15469687)
Biomed Rep. 2014 Jul;2(4):569-573. (PMID: 24944810)
Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jun;29(5):846-58. (PMID: 15908096)
Food Chem Toxicol. 2013 Jan;51:97-105. (PMID: 22847135)
Front Aging Neurosci. 2018 Jun 05;10:169. (PMID: 29922152)
Eur J Pharmacol. 2020 Nov 15;887:173535. (PMID: 32910944)
Pharmaceuticals (Basel). 2020 Sep 03;13(9):. (PMID: 32899148)
Mol Psychiatry. 2002;7(7):673-82. (PMID: 12192610)
Pharmacol Biochem Behav. 2014 Dec;127:101-10. (PMID: 25449356)
J Nutr Gerontol Geriatr. 2012;31(3):206-38. (PMID: 22888839)
Brain Res Bull. 2021 Apr;169:214-227. (PMID: 33370589)
Curr Opin Neurobiol. 2014 Dec;29:88-95. (PMID: 24983212)
J Cell Biochem. 2019 Mar;120(3):3757-3764. (PMID: 30270549)
Life Sci. 2002 Feb 15;70(13):1481-9. (PMID: 11895099)
J Nutr Biochem. 2020 Feb;76:108255. (PMID: 31759198)
Evid Based Complement Alternat Med. 2021 Dec 3;2021:7170736. (PMID: 34899956)
Gut. 2014 Aug;63(8):1210-28. (PMID: 24917550)
J Chromatogr B Biomed Appl. 1996 Aug 30;683(2):225-9. (PMID: 8891919)
Mol Neurobiol. 2018 Dec;55(12):9029-9042. (PMID: 29627876)
J Exp Med. 2007 Nov 26;204(12):2913-23. (PMID: 17984303)
Biochem Pharmacol. 2005 Jan 15;69(2):339-45. (PMID: 15627486)
Toxicology. 2009 Feb 4;256(1-2):128-34. (PMID: 19063931)
Neuroscience. 2012 Dec 13;226:62-72. (PMID: 22999973)
Nutr Neurosci. 2022 Sep;25(9):1898-1908. (PMID: 33856270)
Transl Neurosci. 2021 May 13;12(1):190-197. (PMID: 34046215)
Eur Rev Med Pharmacol Sci. 2017 Apr;21(8):1999-2006. (PMID: 28485774)
J Mol Neurosci. 2021 Jan;71(1):101-111. (PMID: 32557145)
Fitoterapia. 2014 Oct;98:1-10. (PMID: 24932776)
J Psychopharmacol. 2015 Feb;29(2):97-115. (PMID: 25586400)
J Nutr Biochem. 2022 Sep;107:109064. (PMID: 35609850)
BMC Med. 2012 Feb 07;10:13. (PMID: 22313950)
Neuroscience. 2013 Jun 25;241:135-46. (PMID: 23518223)
Biochem Biophys Res Commun. 1999 Nov 19;265(2):410-5. (PMID: 10558881)
J Nutr. 2000 Aug;130(8S Suppl):2073S-85S. (PMID: 10917926)
Mol Cell Biochem. 2015 Nov;409(1-2):199-211. (PMID: 26280522)
Front Immunol. 2019 May 01;10:936. (PMID: 31118933)
Biomed Pharmacother. 2019 Jan;109:536-546. (PMID: 30399589)
Vaccine. 2014 Jul 31;32(35):4450-4456. (PMID: 24962758)
Exp Neurol. 2013 Aug;246:72-83. (PMID: 22285449)
Iran J Public Health. 2019 Dec;48(12):2133-2139. (PMID: 31993381)
Annu Rev Neurosci. 1999;22:123-44. (PMID: 10202534)
فهرسة مساهمة: Keywords: dietary interventions; naringenin; naringin; neurological disease; polyphenols
تواريخ الأحداث: Date Created: 20230121 Latest Revision: 20230202
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC9867091
DOI: 10.3390/life13010099
PMID: 36676048
قاعدة البيانات: MEDLINE
الوصف
تدمد:2075-1729
DOI:10.3390/life13010099